<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The development of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> has been associated with two genetic loci on chromosome 11: WT1 in 11p13 and WT2 in 11p15.5 </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we have used loss of heterozygosity (LOH) in <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumors</z:e> to narrow the WT2 locus distal to the D11S988 locus </plain></SENT>
<SENT sid="2" pm="."><plain>A similar region was apparent for the clinically associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, <z:hpo ids='HP_0006743'>embryonal rhabdomyosarcoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We have also demonstrated that a constitutional chromosome translocation breakpoint associated with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> and an acquired somatic chromosome translocation breakpoint in a <z:e sem="disease" ids="C0206743" disease_type="Neoplastic Process" abbrv="">rhabdoid tumor</z:e> each occur in the same chromosomal interval as the smallest region of LOH in <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumors</z:e> and <z:hpo ids='HP_0006743'>embryonal rhabdomyosarcoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Finally, we report the first <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> without a cytogenetic deletion that shows targeted LOH for 11p15 and 11p13 while maintaining germline status for 11p14 </plain></SENT>
</text></document>